The effects of acute triiodothyronine therapy on myocardial gene expression in brain stem dead cardiac donors

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 3, 2010, Pages 1338-1343

  James, Sally R ^a   Ranasinghe, Aaron M ^a,b   Venkateswaran, Rajamiyer ^b   McCabe, Christopher J ^a   Franklyn, Jayne A ^a   Bonser, Robert S ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; DOPAMINE; INOTROPIC AGENT; LIOTHYRONINE; MESSENGER RNA; NORADRENALIN; PHOSPHOLAMBAN; PLACEBO; POTASSIUM CHANNEL KV1.5; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; VASOPRESSIN;

ADULT; ARTICLE; BOLUS INJECTION; BRAIN DEATH; BRAIN STEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMODYNAMIC PARAMETERS; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; ORGAN DONOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; THYROID FUNCTION TEST; TREATMENT OUTCOME;

EID: 77749239825     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1659     Document Type: Article

References (34)

1. Chopra IJ, Huang TS, Beredo A, Solomon DH, Chua Teco GN, Mead JF 1985 Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses. J Clin Endocrinol Metab 60:666-672
2. Van den Berghe G 2001 The neuroendocrine response to stress is a dynamic process. Best Pract Res Clin Endocrinol Metab 15:405-419
3. Chopra IJ 1997 Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 82:329-334
4. Iglesias P, Munwreath productoz A, Prado F, Guerrero MT, Macías MC, Ridruejo E, Tajada P, Díez JJ 2009 Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin Endocrinol (Oxf) 70:961-967
5. Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L'Abbate A, Donato L 2003 Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 107:708-713
6. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K 1995 Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333:1522-1527
7. Bennett-Guerrero E, Jimenez JL, White WD, D'Amico EB, Baldwin BI, Schwinn DA1996 Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. JAMA 275:687-692
8. Brent GA, Hershman JM 1986 Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 63:1-8
9. Fliers E, Alkemade A, Wiersinga WM 2001 The hypothalamic- pituitary-thyroid axis in critical illness. Best Pract Res Clin Endocrinol Metab 15:453-464
10. Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL 1990 Hormonal changes in brain dead patients. Crit Care Med 18:702-708
11. Cooper DK, Novitzky D, Wicomb WN 1989 The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 71:261-266
12. Taniguchi S, Kitamura S, Kawachi K, Doi Y, Aoyama N 1992 Effects of hormonal supplements on the maintenance of cardiac function in potential donor patients after cerebral death. Eur J Cardiothorac Surg 6:96-101; discussion 102
13. McIver B, Gorman CA 1997 Euthyroid sick syndrome: an overview. Thyroid 7:125-132
14. Novitzky D, Cooper DK, Rosendale JD, Kauffman HM 2006 Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation 82:1396-1401
15. Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, Delmonico FL, Rosengard BR 2003 Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 75:482-487
16. Goarin JP, Cohen S, Riou B, Jacquens Y, Guesde R, Le Bret F, Aurengo A, Coriat P 1996 The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 83:41-47
17. Venkateswaran RV, Steeds RP, Quinn DW, Nightingale P, Wilson IC, Mascaro JG, Thompson RD, Townend JN, Bonser RS 2009 The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J 30:1771-1780
18. Ojamaa K, Sabet A, Kenessey A, Shenoy R, Klein I 1999 Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific. Endocrinology 140:3170-3176
19. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. (Review) N Engl J Med 344:501-509
20. Boelaert K, Tannahill LA, Bulmer JN, Kachilele S, Chan SY, Kim D, Gittoes NJ, Franklyn JA, Kilby MD, McCabe CJ 2003 A potential role for PTTG/securin in the developing human fetal brain. FASEB J 17:1631-1639
21. Ranasinghe AM, McCabe CJ, Quinn DW, James SR, Pagano D, Franklyn JA, Bonser RS 2006 How does glucose insulin potassium improve hemodynamic performance? Evidence for altered expression of β-adrenoreceptor and calcium handling genes. Circulation 114:I239-I244
22. Khoury SF, Hoit BD, Dave V, Pawloski-Dahm CM, Shao Y, Gabel M, Periasamy M, Walsh RA 1996 Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca2+ cycling proteins in the baboon: implications for the force-frequency and relaxation-frequency relationships. Circ Res 79:727-735
23. Kiss E, Brittsan AG, Edes I, Grupp IL, Grupp G, Kranias EG 1998 Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circ Res 83:608-613
24. Hoit BD, Khoury SF, Shao Y, Gabel M, Liggett SB, Walsh RA 1997 Effects of thyroid hormone on cardiac β-adrenergic responsiveness in conscious baboons. Circulation 96:592-598
25. Rohrer D, Dillmann WH 1988 Thyroid hormone markedly increases them RNA coding for sarcoplasmic reticulum Ca2+-ATPase in the rat heart. J Biol Chem 263:6941-6944
26. Ojamaa K, Kenessey A, Klein I 2000 Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology 141:2139-2144
27. Simmerman HK, Jones LR 1998 Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78:921-947
28. Bahouth SW 1991 Thyroid hormones transcriptionally regulate the β1-adrenergic receptor gene in cultured ventricular myocytes. J Biol Chem 266:15863-15869
29. Hing AJ, Hicks M, Garlick SR, Gao L, Kesteven SH, Faddy SC, Wilson MK, Feneley MP, Macdonald PS 2007 The effects of hormone resuscitation on cardiac function and hemodynamics in a porcine brain-dead organ donor model. Am J Transplant 7:809 -817
30. Votapka TV, Canvasser DA, Pennington DG, Koga M, Swartz MT 1996 Effect of triiodothyronine on graft function in a model of heart transplantation. Ann Thorac Surg 62:78-82
31. Novitzky D, Wicomb WN, Cooper DK, Tjaalgard MA 1987 Improved cardiac function following hormonal therapy in brain dead pigs: relevance to organ donation. Cryobiology 24:1-10
32. Jeevanandam V, Todd B, Regillo T, Hellman S, Eldridge C, McClurken J 1994 Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 13:681-687
33. Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, Delmonico FL, Rosengard BR 2003 Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 75:1336-1341
34. Jeevanandam V 1997 Triiodothyronine: spectrum of use in heart transplantation. Thyroid 7:139-145